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VII  SUMMARY 
Effects of vasoactive drugs on systemic and hepatic haemodynamics and oxygenation 
in an animal liver transplant model with different types and times of ischaemia 
 
In the present study the effects of prostacyclin and noradrenaline on systemic and hepatic 
haemodynamics and oxygenation immediately before and after liver transplantation were 
investigated. To clarify if the postoperative effects depend on type and time of hepatic 
ischaemia, the liver allografts were exposed to different types and lengths of ischaemia prior 
to transplantation. The investigation was also expected to determine if in the present 
transplant model alterations in hepatic venous oxygen saturation are reflected in the mixed 
venous oxygen saturation and if a change in systemic haemodynamics is reflected in hepatic 
blood flow.  
24 pigs were divided at prospective random into two groups of 12 pigs each, a donor and a 
recipient group. Depending on type and length of hepatic ischaemia the recipients were 
further divided into two subgroups (n = 6, each). For recipient group A the livers underwent a 
4-hour cold ischaemia before transplantation (preservation in UW-solution). In recipient 
group B the liver allografts were exposed to 1 hour of warm ischaemia prior to the 4-hour 
cold ischaemia. After the necessary instrumentation and a phase of stabilization each animal 
received an intravenous prostacyclin infusion (5 ng/kg/min) for 30 minutes, directly before 
transplantation for donors and directly after transplantation for recipients. 15 minutes later a 
continuous infusion of noradrenaline (0,6 µg/kg/min) was administered for 30 minutes. Data 
of systemic and hepatic haemodynamics and oxygenation were taken before, during and 
after drug administration. 
Only in recipients group A did Prostacyclin lead to a significant improvement in systemic and 
regional haemodynamics (cardiac outflow, FlowAH) and oxygenation (DO2, DHEPO2). During 
administration of noradrenaline, donors showed a distinct decline of liver blood flow without 
impairing the hepatic oxygen supply. Systemic catecholamine effects were not found in 
donors. In both recipient groups administering noradrenaline resulted in a significant 
deterioration of systemic hemondynamics (CO, intravascular pressures)  
(recipients group B > recipients group A). The systemic and hepatic oxygenation remained 
uneffected. 
It was not possible to draw conclusions from mixed venous to hepatic venous oxygen 








The altered reactivity to vasoactive substances of the recipients compared to the healthy 
donors shortly after liver transplantation probably can be attributed to the imbalance between 
endogenous vasodilatators and vasoconstrictors. Seemingly, the 4-hour cold liver ischaemia 
(slight I/R injury) led to a discreet surplus of endogenous vasodilatators. The additional warm 
ischaemia (severe I/R injury) probably led to an increased production of endogenous 
vasoconstrictors. An interaction between these endogenous substances and the 
administered vasoactive drugs apparently led to a mutual strengthening and diminution of 
their particular effects respectively. Additionally, a reduced noradrenaline clearance after the 
transplantation could also be responsible for the increased systemic catecholamine effects in 
the recipients. 
According to the results of our study the success of vasoactive therapy in the acute 
postoperative phase of liver transplantation depends among other things on the severity of 
hepatic I/R injury. It is assumed that systemic and hepatic haemodynamics and oxygenation 
be positively effected by prostacyclin only in recipients of slightly damaged livers. In contrast 
no significant prostacyclin effects can be expected in recipients of more severely injured 
livers. 
Effects of noradrenaline seem to increase with severeness of I/R injury – at least effects on 
systemic haemodynamics (decrease of cardiac output, increase of intravasculare pressures). 
However, since no impairment of systemic or hepatic oxygenation is expected, the 
application of norardrenaline should not be harmful in this respect. 
 
